drugset / Trial / NCT00092833

Investigational Drug in Patients With Hypercholesterolemia or in Patients With Sitosterolemia (0653-026)(COMPLETED)

NCT00092833

Phase 3 Terminated 49 enrolled Organon and Co
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to provide an investigational drug to patients with a specific type of hypercholesterolemia (high cholesterol) or sitosterolemia (unusually high absorption of non-cholesterol sterols) in a treatment use setting.

Timeline

Start
2002-07
Primary completion
2005-05
Completion
2005-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Ezetimibe Unknown 10 mg